SCN1A and Dravet syndrome: Here, the beneficial effect of CAV-SCN1A was mostly examined in DS mice harboring the human A1783V missense mutation (Figures 5–9), with further validation in a second model harboring the human R613X nonsense mutation (Supplemental Figure 14).